This study had some limitations that were identified via the lack of neuropathological confirmation of AD diagnosis, densitometric measurements of Western Blot bands as the sole experimental tool for APP isoform expression, and the statistical analysis of drug influence on platelet metabolism instead of treatment suspension before blood withdrawal, which need to be discussed. The gene discussed is APP; the disease is Alzheimer disease.